JP2022537358A5 - - Google Patents
Info
- Publication number
- JP2022537358A5 JP2022537358A5 JP2021575365A JP2021575365A JP2022537358A5 JP 2022537358 A5 JP2022537358 A5 JP 2022537358A5 JP 2021575365 A JP2021575365 A JP 2021575365A JP 2021575365 A JP2021575365 A JP 2021575365A JP 2022537358 A5 JP2022537358 A5 JP 2022537358A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962864031P | 2019-06-20 | 2019-06-20 | |
| US62/864,031 | 2019-06-20 | ||
| PCT/US2020/038395 WO2020257429A1 (en) | 2019-06-20 | 2020-06-18 | Ectonucleotidase inhibitors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022537358A JP2022537358A (ja) | 2022-08-25 |
| JP2022537358A5 true JP2022537358A5 (https=) | 2023-06-14 |
| JPWO2020257429A5 JPWO2020257429A5 (https=) | 2023-06-14 |
Family
ID=74040909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575365A Withdrawn JP2022537358A (ja) | 2019-06-20 | 2020-06-18 | エクトヌクレオチダーゼ阻害剤およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220363709A1 (https=) |
| EP (1) | EP3986894A4 (https=) |
| JP (1) | JP2022537358A (https=) |
| KR (1) | KR20220024629A (https=) |
| CN (1) | CN114008048A (https=) |
| AU (1) | AU2020294724A1 (https=) |
| CA (1) | CA3143496A1 (https=) |
| WO (1) | WO2020257429A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018208980A1 (en) | 2017-05-10 | 2018-11-15 | Oric Pharmaceuticals, Inc. | Cd73 inhibitors |
| US11377469B2 (en) | 2017-11-03 | 2022-07-05 | Oric Pharmaceuticals, Inc. | CD73 inhibitors |
| CN112423764A (zh) | 2018-04-30 | 2021-02-26 | 欧瑞克制药公司 | Cd73抑制剂 |
| AU2019288495B2 (en) | 2018-06-21 | 2024-02-08 | Antengene Therapeutics Limited | Ectonucleotidase inhibitors and methods of use thereof |
| US12544391B2 (en) | 2019-07-16 | 2026-02-10 | Oric Pharmaceuticals, Inc. | CD73 inhibitors |
| HUE072504T2 (hu) | 2019-10-30 | 2025-11-28 | Oric Pharmaceuticals Inc | CD73-inhibitorok |
| CN119173276A (zh) | 2022-04-13 | 2024-12-20 | 吉利德科学公司 | 用于治疗表达Trop-2的癌症的组合疗法 |
| KR102775989B1 (ko) * | 2022-11-01 | 2025-03-04 | 윤주호 | 콜치신과 메트포르민을 유효성분으로 하는 퇴행성 신경계 질환의 예방 또는 치료용 조성물 |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW528755B (en) * | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| WO2015164573A1 (en) * | 2014-04-25 | 2015-10-29 | Vitae Pharmaceuticals, Inc. | Purine derivatives as cd73 inhibitors for the treatment of cancer |
| TWI767937B (zh) * | 2016-09-09 | 2022-06-21 | 美商卡利泰拉生物科技公司 | 外核苷酸酶抑制劑及其使用方法 |
| JP7138351B2 (ja) * | 2016-12-22 | 2022-09-16 | キャリセラ バイオサイエンシーズ， インコーポレイテッド | エクトヌクレオチダーゼ阻害剤およびその使用方法 |
| AU2019288495B2 (en) * | 2018-06-21 | 2024-02-08 | Antengene Therapeutics Limited | Ectonucleotidase inhibitors and methods of use thereof |
-
2020
- 2020-06-18 KR KR1020227001589A patent/KR20220024629A/ko not_active Withdrawn
- 2020-06-18 CN CN202080045115.6A patent/CN114008048A/zh active Pending
- 2020-06-18 CA CA3143496A patent/CA3143496A1/en active Pending
- 2020-06-18 AU AU2020294724A patent/AU2020294724A1/en not_active Abandoned
- 2020-06-18 JP JP2021575365A patent/JP2022537358A/ja not_active Withdrawn
- 2020-06-18 US US17/620,508 patent/US20220363709A1/en not_active Abandoned
- 2020-06-18 EP EP20826073.7A patent/EP3986894A4/en not_active Withdrawn
- 2020-06-18 WO PCT/US2020/038395 patent/WO2020257429A1/en not_active Ceased